Iyer V K, Raina V, Dawar R
Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Indian J Cancer. 2000 Dec;37(4):140-7.
Silver stained Nucleolar Organiser Region (AgNOR) counting is a well established method of estimating the proliferative activity of a tumour. Their utility in prognostication in Non Hodgkin's Lymphoma (NHL) has not been fully investigated. We analysed hundred cases of NHL, all of which had a minimum of two and a half years of follow up, using histology by International Working Formulation (IWF) and their AgNOR scores. We found the IWF grading to have a good correlation with the outcome. The two and a half year survival for low grade NHL was 90 percent, for intermediate grade NHL was 47 percent and for high grade NHL was 30 percent. AgNOR scores correlated well with IWF grading and classification, with average AgNOR score of 1.82 (SD 0.34) in low grade NHL; 4.47 (SD 2.25) in intermediate grade NHL and 7.07 (SD 4.40) in high grade NHL. Over histology, AgNOR counting yielded additional prognostic information only in the diffuse small cleaved cell NHL (DSC), where finely dispersed NORs were seen. Of the 22 case of DSC included, 11 cases with AgNOR scores less than three had a much better outcome with 75 percent survival at two and a half years. Cases of DSC with AgNOR scores greater than three had a significantly worse outcome with only 25 percent survival at two and a half years (p=0.0103). Such sub-stratification could not be done in any other catergory of NHL using AgNOR scores. Thus, counting of AgNORs in lymphomas with finely dispersed NORs as in DSC is of prognostic value.
银染核仁组成区(AgNOR)计数是一种成熟的估计肿瘤增殖活性的方法。其在非霍奇金淋巴瘤(NHL)预后评估中的作用尚未得到充分研究。我们分析了100例NHL病例,所有病例均至少随访了两年半,采用国际工作分类法(IWF)进行组织学检查并计算其AgNOR评分。我们发现IWF分级与预后有良好的相关性。低级别NHL的两年半生存率为90%,中级别的为47%,高级别的为30%。AgNOR评分与IWF分级和分类有很好的相关性,低级别NHL的平均AgNOR评分为1.82(标准差0.34);中级别的为4.47(标准差2.25),高级别的为7.07(标准差4.40)。在组织学方面,AgNOR计数仅在弥漫性小裂细胞NHL(DSC)中产生了额外的预后信息,其中可见精细分散的NORs。在纳入的22例DSC病例中,11例AgNOR评分低于3分的患者预后要好得多,两年半生存率为75%。AgNOR评分大于3分的DSC病例预后明显较差,两年半生存率仅为25%(p=0.0103)。使用AgNOR评分无法在任何其他NHL类别中进行这种亚分层。因此,在如DSC中具有精细分散NORs的淋巴瘤中计数AgNOR具有预后价值。